Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute

VANCOUVER, British Columbia, April 09, 2024 -- Optimi Health Corp.  , a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as...

Related Keywords

Gisborne ,New Zealand General ,New Zealand ,Vancouver ,British Columbia ,Canada ,Matai ,Waikato ,United Kingdom ,Auckland ,Wairua ,British ,Canadian ,Rangiwaho Marae ,Michael Kydd ,Patrick Mchugh ,Rua Bioscience ,Jody Toroa ,University Of Auckland ,University Of Waikato ,Neither The Canadian Securities Exchange ,Manaaki Whenua Landcare Research ,Devices Safety Authority Medsafe ,Optimi Health Corp ,Community Liaison ,Investment Industry Regulatory Organization Of Canada ,Health Canada ,Optimi Health ,Research Institute ,Medical Research Institute ,Spectrum Natural Psilocybin ,Natural Psilocybin ,Psilocybin Administration ,Healthy Volunteers ,Marae Setting ,First Nations ,New Zealand Medicines ,Medical Devices Safety Authority ,Gisborne Tair ,Medical Research ,Canadian Securities Exchange ,Investment Industry Regulatory Organization ,Markets ,